COM:ULTRAGENYX
Ultragenyx Pharmaceutical Inc.
- Stock
Last Close
50.43
08/11 21:00
Market Cap
3.85B
Beta: -
Volume Today
1.23M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -35.07M - | -59.80M 70.52% | -145.62M 143.50% | -245.87M 68.85% | -302.14M 22.88% | -197.61M 34.60% | -402.73M 103.80% | -186.57M 53.67% | -454.02M 143.36% | -707.42M 55.81% | -606.64M 14.25% | |
depreciation and amortization | 444K - | 684K 54.05% | 1.38M 102.34% | 3.42M 147.40% | 5.83M 70.12% | 19.54M 235.42% | 8.54M 56.30% | 12.26M 43.59% | 13.24M 7.98% | 18.22M 37.62% | 26.01M 42.73% | |
deferred income tax | 6.16M - | -16.25M 363.56% | -167.65M 931.97% | -18.94M 88.70% | -169.78M 796.44% | 48.67M 128.67% | -1.64M 103.37% | -1.62M 1.22% | ||||
stock based compensation | 657K - | 5.39M 721.00% | 24.88M 361.33% | 48.31M 94.14% | 68.01M 40.79% | 80.11M 17.78% | 82.00M 2.36% | 85.73M 4.56% | 104.95M 22.41% | 130.38M 24.23% | 135.23M 3.72% | |
change in working capital | -1.54M - | 2.17M 240.19% | 7.74M 257.16% | 26.30M 239.99% | -20.23M 176.92% | -24.79M 22.53% | -15.94M 35.69% | 104.66M 756.48% | -63.24M 160.42% | 60.23M 195.25% | -15.10M 125.07% | |
accounts receivables | -7.58M - | -20.10M 165.12% | 9.84M 148.95% | -5.43M 155.20% | -12.07M 122.16% | -22.78M 88.75% | ||||||
inventory | -5.28M - | -4.45M 15.75% | -1.35M 69.76% | -3.12M 131.58% | -9.70M 211.23% | -6.93M 28.56% | ||||||
accounts payables | 237K - | 3.18M 1,240.51% | -1.98M 162.39% | 2.50M 226.24% | 3.46M 38.25% | 3.37M 2.52% | 20.65M 512.34% | 29.60M 43.36% | 2.81M 90.52% | 87.44M 3,017.36% | 2.38M 97.28% | |
other working capital | -1.78M - | -1.01M 43.27% | 9.72M 1,061.23% | 23.80M 144.91% | -23.69M 199.54% | -15.30M 35.43% | -12.04M 21.31% | 66.57M 653.07% | -57.49M 186.37% | -5.44M 90.54% | 12.23M 324.84% | |
other non cash items | 4.31M - | 6.92M 60.50% | 5.64M 18.59% | 700K 87.58% | 10.93M 1,462% | -156K 101.43% | 1.69M 1,184.62% | 21.46M 1,168.50% | 11.71M 45.46% | 119.76M 923.09% | -12.68M 110.59% | |
net cash provided by operating activities | -31.20M - | -44.63M 43.06% | -105.98M 137.44% | -160.97M 51.90% | -253.84M 57.69% | -290.57M 14.47% | -345.38M 18.87% | -132.22M 61.72% | -338.69M 156.16% | -380.46M 12.33% | -474.81M 24.80% | |
investments in property plant and equipment | -407K - | -2.15M 428.01% | -4.96M 130.57% | -10.19M 105.61% | -2.79M 72.59% | -4.08M 45.94% | -24.83M 509.22% | -43.91M 76.81% | -73.09M 66.48% | -146.12M 99.91% | -46.77M 67.99% | |
acquisitions net | -142.80M - | -11.79M - | -75.03M - | -2.50M 96.67% | ||||||||
purchases of investments | -63.95M - | -208.97M 226.76% | -624.23M 198.71% | -442.49M 29.11% | -230.49M 47.91% | -509.80M 121.18% | -707.16M 38.71% | -850.30M 20.24% | -1.01B 19.04% | -614.74M 39.27% | -526.38M 14.37% | |
sales maturities of investments | 16.60M - | 87.97M 429.93% | 338.37M 284.63% | 543.79M 60.71% | 431.57M 20.64% | 310.22M 28.12% | 718.96M 131.76% | 720.64M 0.23% | 890.85M 23.62% | 545.08M 38.81% | 746.20M 36.90% | |
other investing activites | 25K - | -293K 1,272% | -1.54M 425.94% | -1.20M 22.00% | 934K 177.70% | 170.32M 18,135.76% | 11.79M 93.08% | -5.55M 147.10% | -942K 83.04% | -844K 10.40% | -2.55M 201.90% | |
net cash used for investing activites | -47.73M - | -123.44M 158.60% | -292.35M 136.84% | 89.92M 130.76% | 56.42M 37.26% | -33.33M 159.08% | -13.04M 60.88% | -179.12M 1,273.73% | -195.37M 9.07% | -291.65M 49.28% | 168M 157.60% | |
debt repayment | -4.94M - | -314.23M - | -490.95M - | |||||||||
common stock issued | 171K - | 189.32M 110,611.70% | 467.57M 146.98% | 79.49M 83.00% | 131.96M 66.02% | 309.02M 134.18% | 355.24M 14.96% | 511.21M 43.91% | 78.94M 84.56% | 10.81M 86.30% | 379.75M 3,412.02% | |
common stock repurchased | ||||||||||||
dividends paid | -4.35M - | |||||||||||
other financing activites | 59.19M - | 9.25M 84.37% | 27.83M 200.81% | 638.30M 2,193.72% | 89.06M 86.05% | 39.61M 55.52% | 981.35M 2,377.58% | 8.39M 99.15% | ||||
net cash used provided by financing activities | 171K - | 184.97M 108,070.18% | 467.57M 152.78% | 138.68M 70.34% | 136.27M 1.74% | 336.85M 147.20% | 679.31M 101.66% | 600.27M 11.63% | 118.55M 80.25% | 501.21M 322.77% | 388.14M 22.56% | |
effect of forex changes on cash | -65K - | 528K 912.31% | -472K 189.39% | -165K 65.04% | 1.12M 778.18% | -1.19M 206.70% | -1.07M 9.97% | 462K 142.98% | ||||
net change in cash | -78.76M - | 16.90M 121.45% | 69.25M 309.81% | 67.55M 2.45% | -60.63M 189.76% | 12.48M 120.59% | 320.72M 2,469.04% | 290.05M 9.56% | -416.71M 243.67% | -171.98M 58.73% | 85.59M 149.77% | |
cash at beginning of period | 86.19M - | 7.43M 91.38% | 24.32M 227.51% | 93.57M 284.68% | 161.12M 72.19% | 103.04M 36.05% | 115.53M 12.12% | 436.24M 277.62% | 726.29M 66.49% | 309.58M 57.37% | 133.81M 56.78% | |
cash at end of period | 7.43M - | 24.32M 227.51% | 93.57M 284.68% | 161.12M 72.19% | 100.49M 37.63% | 115.53M 14.96% | 436.24M 277.62% | 726.29M 66.49% | 309.58M 57.37% | 137.60M 55.55% | 219.40M 59.45% | |
operating cash flow | -31.20M - | -44.63M 43.06% | -105.98M 137.44% | -160.97M 51.90% | -253.84M 57.69% | -290.57M 14.47% | -345.38M 18.87% | -132.22M 61.72% | -338.69M 156.16% | -380.46M 12.33% | -474.81M 24.80% | |
capital expenditure | -407K - | -2.15M 428.01% | -4.96M 130.57% | -10.19M 105.61% | -2.79M 72.59% | -4.08M 45.94% | -24.83M 509.22% | -43.91M 76.81% | -73.09M 66.48% | -146.12M 99.91% | -46.77M 67.99% | |
free cash flow | -31.61M - | -46.78M 48.01% | -110.93M 137.12% | -171.16M 54.30% | -256.64M 49.94% | -294.64M 14.81% | -370.21M 25.65% | -176.13M 52.43% | -411.79M 133.80% | -526.59M 27.88% | -521.57M 0.95% |
All numbers in (except ratios and percentages)